Ontology highlight
ABSTRACT:
SUBMITTER: Oh J
PROVIDER: S-EPMC4206621 | biostudies-literature | 2014 Sep
REPOSITORIES: biostudies-literature
Therapeutic advances in neurological disorders 20140901 5
A number of novel oral agents are now approved for use in relapsing multiple sclerosis (MS). Among these agents, teriflunomide has shown promise with respect to clinical efficacy and safety in relapsing MS patients. In this review we aim to clarify the role of teriflunomide in the context of current and emerging MS treatment options by summarizing relevant points on the use of teriflunomide in MS, with a discussion of teriflunomide's pharmacologic properties, pivotal clinical trials, and safety ...[more]